Selling a Medical or Aesthetic Practice in Nevada

There is no single statute. Nevada’s corporate-practice-of-medicine doctrine is drawn from a chain of Attorney General Opinions from 1977, 2002, and 2010, read together with Nevada’s professional-entity rules. Counsel point to NRS 630.020, which defines the practice of medicine, NRS Chapter 78, the general for-profit corporation chapter that may not practice medicine, and NRS Chapter 89, the professional-entity chapter, where NRS 89.040 requires that every individual involved in forming the professional entity hold the authorization to provide that professional service. A 2023 effort to codify the doctrine was vetoed by Governor Lombardo, and counsel describe Nevada as having a relatively stricter ban with an active state medical board, so the rule is real even though it is not written in one place.

No. There is no published Nevada-specific multiple, and we will not quote one. What we use is the national vertical range for your practice type, then we explain how Nevada law and market move structure and value. A practice that is already cleanly structured for compliance, with a defensible physician-owned PC, a clean management services agreement, and documented licensure for everyone performing treatments, transacts faster and holds its value. A practice that is not invites re-trading and discounts. Your real number comes from a confidential, practice-specific analysis.

Demand for aesthetic practices is national, not a single local buyer pool, and several national platforms already operate physical clinics in Nevada. LaserAway, a national aesthetic chain of more than 120 locations, runs Las Vegas clinics including 6551 Las Vegas Blvd S, Ste R-144, Las Vegas, NV 89119 and a location on W Charleston Blvd. Vivida Dermatology, a board-certified dermatology and Mohs group, operates in Las Vegas and Henderson, Nevada, and St. George, Utah. On the private-equity side, the American Med Spa Association reports roughly 50 private-equity groups active in aesthetics, with active consolidators including MedSpa Partners, backed by Persistence Capital Partners, and Advanced MedAesthetic Partners, backed by Leon Capital Group. The accurate picture is national capital buying into Nevada, not one local acquirer.

Nevada is a smaller state by population but a major destination market. AmSpa’s State of the Medical Spa Industry report publishes a national med spa count only, with no state-by-state breakdown or ranking, so we will not cite an uncitable Nevada figure. What is verifiable is Nevada’s roughly 3.3 million residents plus tens of millions of annual visitors to Las Vegas, a tourism base that supports a different kind of demand than population alone would suggest. For a seller that is a useful signal: buyers can be selective in a smaller-population state, so a differentiated practice with recurring revenue, provider depth, and a transferable patient base stands out and pulls toward the top of the national range.

Yes, unless and until you choose to tell people. We run every process under strict confidentiality, with confidentiality agreements, secure data rooms, staged disclosure, and a vetted buyer process. Premature disclosure can unsettle staff, shake patient confidence, and weaken your negotiating position, so you decide what is shared, with whom, and when. Because a Nevada deal is built as a two-entity friendly-PC and MSO structure, we plan that structure with you openly and privately from the first conversation.